Advertisement
Screener

Maravai LifeSciences Holdings, Inc. (MRVI) Limited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement

1.3 / 5 stars · 16/60 Roast Me

Maravai LifeSciences Holdings, Inc. Limited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement

Maravai LifeSciences Holdings, Inc. (MRVI) reported Limited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement of $3.28 million for the 11-month period ending 2020-11-19, per its 10-K filed 2023-02-28.

Discontinued › Expense Statement › Operating Expenses

us-gaap:LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation · last filed 2023-02-28

  • Maravai LifeSciences Holdings, Inc. limited liability company (llc) members' equity, unit-based payment arrangement for the quarter ending 2020-09-30 was $1.85M.
  • Maravai LifeSciences Holdings, Inc. limited liability company (llc) members' equity, unit-based payment arrangement for the quarter ending 2020-06-30 was $576.00K.
  • Maravai LifeSciences Holdings, Inc. limited liability company (llc) members' equity, unit-based payment arrangement for the quarter ending 2020-03-31 was $508.00K.
  • Maravai LifeSciences Holdings, Inc. limited liability company (llc) members' equity, unit-based payment arrangement for fiscal 2019 was $1.68M.
Period endLimited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement 3 monthLimited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement 6 monthLimited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement 9 monthLimited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement 11 monthLimited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement 12 month
2020-11-19$3.28M
10-K · filed 2023-02-28
2020-09-30$1.85M
10-Q · filed 2021-11-15
$2.42M
derived: sum of 2 quarters · filed 2021-11-15
$2.93M
10-Q · filed 2021-11-15
2020-06-30$576.00K
10-Q · filed 2021-08-11
$1.08M
10-Q · filed 2021-08-11
2020-03-31$508.00K
10-Q · filed 2021-05-12
2019-12-31$1.68M
10-K · filed 2022-03-01